Coca-Cola Consolidated, Inc.
COKE
$196.24
+2.28%
Coca-Cola Consolidated, Inc. is the largest independent Coca-Cola bottler in the United States, manufacturing, marketing, and distributing a broad portfolio of nonalcoholic beverages — sparkling sodas, bottled water, ready-to-drink tea and coffee, enhanced water, juices, and sports drinks — across a multi-state territory. Unlike The Coca-Cola Company, which owns the trademarks and concentrates on brand and syrup production, COKE operates the capital-intensive bottling and distribution infrastructure, giving it a distinct position as a franchisee with exclusive territorial rights rather than a brand owner. The current investor narrative centers on the company's aggressive share-repurchase program — which has dramatically reduced the share count and amplified per-share earnings — alongside steady low-double-digit revenue growth and improving operating leverage. Debate among investors focuses on whether the buyback-driven EPS uplift is sustainable, how much further margin expansion is possible in a mature, low-growth category, and whether the stock's strong one-year outperformance has already priced in these gains.…
COKE
Coca-Cola Consolidated, Inc.
$196.24
Investment Opinion: Should I buy COKE Today?
Based on the synthesis of available data, COKE warrants a Hold rating. The company's strong revenue growth, robust free cash flow, and defensive characteristics are offset by margin pressures, lack of analyst coverage, and a valuation that appears fair-to-slightly-rich. The absence of a consensus target price makes it difficult to gauge upside, but the trailing PE of 19.78x and PS of 1.56x suggest the stock is reasonably valued relative to its history and peers.
Supporting evidence for a Hold includes: 1) Revenue growth of 10.6% YoY in Q2 2026, 2) Free cash flow of $644.7 million TTM, 3) A low beta of 0.547 providing downside protection, and 4) A dividend yield of 0.77% with a low payout ratio of 15.2%, indicating room for future increases. However, the net margin has compressed to 7.74% from 10.10%, and interest expense has surged, which could limit earnings growth. The forward PE of 4.93x is likely a data anomaly and should not be relied upon.
The biggest risks that could invalidate the thesis include a continued rise in interest expenses, a slowdown in revenue growth, and the lack of institutional support. The rating would upgrade to Buy if the company demonstrates sustained margin expansion and revenue growth above 12%, or if the stock price pulls back to the $160-$165 support zone. Conversely, a downgrade to Sell would occur if revenue growth falls below 8% or if free cash flow turns negative. Overall, the stock appears fairly valued, with limited margin of safety at current levels.
Sign up to view all
COKE 12-Month Price Forecast
COKE presents a balanced risk-reward profile, with steady revenue growth and strong cash flow offset by margin pressures and limited analyst attention. The stock's low beta makes it a defensive holding, but its recent underperformance and premium PEG ratio suggest limited upside in the near term. The base case is most likely, with the stock trading in a range. An upgrade to bullish would require sustained margin expansion and revenue growth above 12%, while a downgrade to bearish would occur if margins fall below 7% or revenue growth stalls.
Wall Street consensus
Insufficient analyst coverage available. Only 1 analyst covers COKE, and the recommendation field is "none" with no consensus target price, no estimated EPS figures (all zero), and no Buy/Hold/Sell distribution. The sole revenue estimate of $7.228 billion is a single point estimate with no range, indicating minimal institutional engagement. This lack of coverage is typical for a mid-cap bottler with a concentrated ownership structure and limited float, and it means there is no reliable consensus target to calculate implied upside or downside from the current price of $192.04.
The absence of meaningful analyst coverage has several implications: price discovery is less efficient, volatility can be higher around earnings, and institutional investors may avoid the name due to liquidity constraints. The institutional ratings history shows only Citigroup maintaining a "Neutral" rating repeatedly from 2012 through 2016, with no updates in the past decade — suggesting the stock has fallen off most sell-side radar. For investors, this means relying on fundamental analysis and cash flow metrics rather than consensus targets, and being prepared for wider bid-ask spreads and potential sharp moves on news. The wide gap between the trailing PE of 19.78x and the anomalous forward PE of 4.93x further underscores the unreliability of analyst-derived metrics for this stock.
Bulls vs Bears: COKE Investment Factors
The bull case for COKE rests on its consistent revenue growth, strong free cash flow, and shareholder-friendly capital allocation, all supported by a defensive, low-beta profile. However, the bear case highlights margin compression, rising interest costs, and a lack of analyst coverage that could limit upside. Currently, the bear evidence appears slightly stronger due to recent underperformance and profitability pressures, but the long-term trend remains positive. The most critical tension is whether the company can sustain its revenue growth and margin recovery in the face of increasing interest expenses. Resolution of this factor will likely determine the stock's direction over the next year.
Bullish
- Strong Revenue Growth: COKE delivered 10.6% YoY revenue growth in Q2 2026 to $2.052 billion, following 16.9% YoY growth in Q1 2026. This consistent double-digit expansion in a mature, defensive category demonstrates pricing power and share gains.
- Robust Free Cash Flow: Trailing twelve-month free cash flow stands at $644.7 million, with Q2 2026 generating $131.1 million. This strong cash generation supports the company's aggressive share buybacks and dividend payments.
- Attractive Valuation Metrics: The stock trades at a trailing PE of 19.78x and a PS ratio of 1.56x, which is below the typical 2.0x-3.0x range for branded beverage peers. The EV/EBITDA of 13.55x is in line with bottling peers, suggesting fair valuation.
- Low Volatility Defensive Profile: With a beta of 0.547, COKE is roughly 45% less volatile than the broader market. This makes it an attractive holding for risk-averse investors seeking stable returns in uncertain markets.
Bearish
- Margin Compression and Rising Interest Expense: Q2 2026 net margin fell to 7.74% from 10.10% in Q2 2025, while interest expense surged to $30.5 million from $5.9 million. This pressure on profitability could persist if debt costs remain elevated.
- Negative Shareholders' Equity and High Leverage: The debt-to-equity ratio is -4.06 and ROE is -77.13% due to negative book equity from massive buybacks. While not immediately distressed, this limits financial flexibility and distorts leverage metrics.
- Lack of Analyst Coverage and Consensus: Only one analyst covers COKE, with no consensus target price or EPS estimates. This lack of institutional engagement reduces price discovery efficiency and can lead to higher volatility around earnings.
- Recent Underperformance and Consolidation: Over the past 3 and 6 months, COKE has underperformed SPY by 5.18 and 18.71 percentage points, respectively. The stock has been range-bound since April 2026, suggesting momentum has stalled.
COKE Technical Analysis
COKE is in a sustained uptrend over the trailing twelve months, with a 1-year price change of +60.97% versus SPY's +15.01%, delivering relative strength of +45.96 percentage points. At the current price of $192.04, the stock sits at approximately 72.8% of its 52-week range (low of $118.02, high of $219.65), meaning it has pulled back from its highs but remains firmly in the upper half of its annual band. This positioning suggests the long-term momentum remains intact, though the stock is no longer at breakout levels and has entered a consolidation phase after a powerful run. The max drawdown of -24.66% indicates the stock has experienced a meaningful correction from peak levels, consistent with a maturing uptrend rather than a broken one.
Short-term momentum has clearly decelerated and diverges from the strong annual trend: the 1-month change is -1.65% and the 3-month change is -1.84%, both negative, while the 6-month change is -1.36%. This flat-to-negative intermediate performance contrasts sharply with the +60.97% annual gain, signaling that the stock has been range-bound since roughly April 2026, oscillating between the $160s and $200s. Relative strength versus SPY is negative across all short windows — -2.24 over 1 month, -5.18 over 3 months, and -18.71 over 6 months — confirming the stock is underperforming the market during this consolidation. The most recent session showed a +2.63% bounce on volume of 458,182 shares, but without RSI data available, the pattern suggests a temporary pullback within a longer-term uptrend rather than a confirmed trend reversal.
Key technical support rests at the 52-week low of $118.02, with a more immediate support zone around the $160-$165 area where the stock bottomed in May 2026 (closing at $163.43 on May 14). Resistance is defined by the 52-week high of $219.65, with intermediate resistance near the $200-$205 zone that has capped multiple rally attempts. A breakout above $219.65 would signal renewed momentum and likely target new highs, while a breakdown below $160 would threaten the uptrend structure and could open the door to a retest of the $118 low. The beta of 0.547 is notably low — roughly 45% less volatile than the market — which means COKE tends to move less than SPY in either direction, making it attractive for risk-averse positioning but also limiting upside capture during broad market rallies.
Beta
0.54
0.54x market volatility
Max Drawdown
-24.7%
Largest decline past year
52-Week Range
$123-$220
Price range past year
Annual Return
+59.3%
Cumulative gain past year
| Period | COKE Return | S&P 500 |
|---|---|---|
| 1m | +3.8% | +2.1% |
| 3m | +9.4% | +3.1% |
| 6m | -3.5% | +14.6% |
| 1y | +59.3% | +16.0% |
| ytd | +31.0% | +14.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COKE Fundamental Analysis
COKE's revenue trajectory is solidly positive, with the most recent quarter (Q2 2026, ended July 3) delivering $2.052 billion in revenue, up 10.61% year-over-year from $1.856 billion in Q2 2025. The multi-quarter trend shows consistent growth: Q1 2026 revenue of $1.847 billion versus Q1 2025's $1.580 billion (+16.9% YoY), and Q4 2025 revenue of $1.904 billion versus Q4 2024's $1.746 billion (+9.0% YoY). The Nonalcoholic Beverage segment dominates with $2.039 billion of the $2.052 billion total, while the Other segment contributes just $92.3 million, meaning growth is almost entirely driven by the core beverage business. This steady top-line expansion in a mature, defensive category implies the company is gaining share or benefiting from favorable pricing, supporting the investment case for a reliable compounder.
Profitability is robust and improving: Q2 2026 net income was $158.8 million on a 7.74% net margin, with gross margin at 37.93% and operating margin at 13.22%. Comparing year-over-year, Q2 2025 net income was $187.4 million (10.10% net margin) on $1.856 billion revenue, so while absolute net income declined, the revenue base expanded — the margin compression reflects higher interest expense ($30.5 million in Q2 2026 versus $5.9 million in Q2 2025) and increased SG&A. Gross margin has been remarkably stable, ranging from 37.93% to 39.37% over the past five quarters, which is typical for a bottler with significant fixed costs and long-term supply agreements. The trailing PE of 19.78x and forward PE of 4.93x suggest the market expects a substantial earnings rebound, though the forward estimate appears anomalously low and may reflect a data artifact rather than genuine analyst consensus.
Balance sheet and cash flow metrics present a mixed picture: free cash flow TTM is $644.7 million, and Q2 2026 free cash flow was $131.1 million, down from $264.1 million in Q3 2025 but still positive. The current ratio of 1.26 indicates adequate short-term liquidity, and ROA of 12.46% is healthy for a capital-intensive bottler. However, the debt-to-equity ratio of -4.06 and ROE of -77.13% are negative due to negative shareholders' equity — a consequence of the company's massive share buybacks ($2.46 billion in Q4 2025 alone) that have depleted book equity. While this accounting artifact doesn't signal distress, it does mean traditional leverage metrics are distorted; the company's interest coverage of 8.9x and operating cash flow of $215.4 million in Q2 2026 suggest it can service its debt, but the aggressive capital return strategy leaves little margin for error if cash flows deteriorate.
Quarterly Revenue
$2.1B
2026-07
Revenue YoY Growth
+10.6%
YoY Comparison
Gross Margin
37.9%
Latest Quarter
Free Cash Flow
$644707000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COKE Overvalued?
Because COKE reported positive net income of $158.8 million in Q2 2026, the PE ratio is the appropriate primary valuation metric. The trailing PE stands at 19.78x, while the forward PE is 4.93x — an unusually wide gap that implies the market expects earnings to more than quadruple, which is almost certainly a data anomaly given the company's stable earnings history. A more reliable read comes from the PS ratio of 1.56x and EV/EBITDA of 13.55x, which are more consistent with a mature, low-growth bottler. The trailing PE of 19.78x is reasonable for a defensive consumer staples name with steady cash flows, but the forward PE discrepancy warrants caution in relying on that figure.
Relative to the broader Consumer Defensive sector, COKE's PS ratio of 1.56x appears inexpensive compared to typical sector averages of 2.0x-3.0x for branded beverage companies, though bottlers structurally trade at lower multiples than brand owners due to lower margins and capital intensity. The EV/EBITDA of 13.55x is in line with bottling peers, and the PCF ratio of 12.05x suggests the stock is reasonably valued on a cash flow basis. The PEG ratio of 1.87x indicates the stock is trading at a premium to its growth rate, which is typical for a low-growth, high-cash-return business. Without specific industry average data provided, the most defensible conclusion is that COKE trades at a modest discount to branded beverage peers but at a fair valuation relative to its own cash-generation profile.
Historically, COKE's PE ratio has ranged widely: it was 20.46x in Q2 2026, 24.71x in Q1 2026, 20.83x in Q4 2025, and as low as 12.96x in Q2 2025. The current 19.78x sits near the middle-to-upper end of this two-year range, suggesting the market is pricing in stable-to-improving fundamentals rather than deep pessimism. The PS ratio of 1.56x is dramatically lower than the 5.9x-6.3x range seen in 2025-2026 historical data, but that discrepancy likely reflects a change in share count or data methodology rather than a true valuation collapse. Overall, the valuation appears fair-to-slightly-rich relative to the company's own history, with the stock's strong 1-year price gain having already captured much of the fundamental improvement.
PE
19.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 8x~29x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
COKE faces financial risks stemming from its aggressive share repurchase program, which has depleted shareholders' equity to -$4.06 debt-to-equity and resulted in a negative ROE of -77.13%. While this accounting artifact does not signal immediate distress, it leaves little room for error if cash flows deteriorate. Interest expense has risen sharply to $30.5 million in Q2 2026 from $5.9 million a year earlier, compressing net margins to 7.74% from 10.10%. Additionally, the company's current ratio of 1.26 is adequate but not robust, and free cash flow, while positive at $644.7 million TTM, could be pressured by further debt servicing costs.
Market and competitive risks include the stock's premium valuation relative to its growth prospects, as evidenced by a PEG ratio of 1.87x. With a beta of 0.547, COKE is less volatile than the market, but this also means it may lag during broad rallies. The lack of analyst coverage (only one analyst) reduces price discovery and can lead to sharp moves on news. Furthermore, the company operates in a mature, low-growth category, and any acceleration in input cost inflation or competitive pressures from other beverage distributors could erode margins. Recent underperformance versus SPY over the past 3 and 6 months (-5.18 and -18.71 percentage points, respectively) suggests waning momentum.
In a worst-case scenario, a combination of declining revenue growth, further margin compression, and rising interest rates could trigger a significant sell-off. The stock's 52-week low is $118.02, representing a potential downside of approximately 38.5% from the current price of $192.04. If the company fails to sustain its growth trajectory and investor sentiment sours, the stock could retest that low. Additionally, the max drawdown over the past year was -24.66%, indicating that a correction of that magnitude is plausible. In such an adverse scenario, investors could lose over a third of their investment.
FAQ
The key risks include: 1) Financial risk from negative shareholders' equity and high debt-to-equity of -4.06, which limits financial flexibility; 2) Margin risk as net margin compressed to 7.74% in Q2 2026 from 10.10% a year earlier, with interest expense rising to $30.5 million; 3) Market risk due to lack of analyst coverage and low liquidity, which can lead to volatility; and 4) Competitive risk from the mature beverage category, where pricing pressure and changing consumer preferences could impact growth. These risks are ranked from most to least severe, with financial and margin risks being the most immediate.
Our 12-month forecast for COKE includes three scenarios: a bull case with 25% probability targeting $220-$240, a base case with 55% probability targeting $190-$210, and a bear case with 20% probability targeting $118-$150. The base case is most likely, assuming revenue growth of 8-10% and stable margins. The bull case requires margin recovery and accelerated growth, while the bear case assumes a significant slowdown. The current price of $192.04 is near the lower end of the base case range, suggesting limited upside in the near term without a catalyst.
COKE appears fairly valued to slightly overvalued based on traditional metrics. The trailing PE of 19.78x is in line with its historical average, while the PS ratio of 1.56x is below the sector average of 2.0x-3.0x. However, the PEG ratio of 1.87x suggests a premium relative to growth. The EV/EBITDA of 13.55x is consistent with bottling peers. The market seems to be pricing in stable growth and continued capital returns, but not significant multiple expansion. Without a clear catalyst, the stock may struggle to break out of its current range.
COKE may be a good buy for risk-averse investors seeking a defensive holding with steady growth and income. The stock trades at a trailing PE of 19.78x and offers a dividend yield of 0.77%, with revenue growing at 10.6% YoY. However, margin compression and rising interest expenses pose risks, and the lack of analyst coverage means less institutional support. The potential upside to the 52-week high of $219.65 is about 14%, while downside to the 52-week low of $118.02 is 38.5%. Therefore, it is more suitable for long-term investors comfortable with moderate volatility and seeking stable returns.
COKE is more suitable for long-term investment due to its defensive characteristics, low beta of 0.547, and steady dividend. The company's consistent revenue growth and strong free cash flow support a buy-and-hold strategy. Short-term trading is less attractive given the lack of analyst coverage and recent range-bound performance. A minimum holding period of 2-3 years is recommended to ride out potential volatility and benefit from the company's capital return programs. The stock's low volatility makes it a good candidate for a core portfolio holding.